Europe Epigenetics Diagnostic Market Research Report: Forecast (2025-2030)

Europe Epigenetics Diagnostic Market - By Product & Service (Kits & Reagents, Enzymes, Instruments & Accessories, Software, Services), By Method (DNA Methylation, Histone Modificat......ions, Others), By Technique (NGS, PCR & qPCR, Mass Spectrometry, Sonication, Others), By Application (Oncology, Metabolic Diseases, Immunology, Development Biology, Cardiovascular Diseases, Others), By End-User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others) and others Read more

  • Healthcare
  • Mar 2025
  • 153
  • PDF, Excel, PPT

Market Definition

Epigenetic diagnostics is the process of examining the effect of environmental factors, such as diet, stress, physical activity, pollution, etc., on the genes of a human body that change their functioning.

Market Insights & Analysis: Europe Epigenetics Diagnostic Market (2025-30):

The Europe Epigenetics Diagnostic Market size was valued at around USD 5.4 billion in 2024 and is projected to reach USD 13 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 15.8% during the forecast period, i.e., 2025-30. The main reasons behind this growth are the growing demand for personalized medicines, early detection of harmful chronic diseases, reduced treatment costs, enhanced treatment efficiency, and continuous investments in research and development. This is because epigenetic diagnostics helps the healthcare providers in accurately knowing about the infecting cell and give a targeted treatment to the patient which helps in reducing the cost and precisely treating the disease. Such investments also align with regional trends of rising chronic diseases, aging populations, and increasing healthcare awareness.

Report Coverage Details
  Historical Years   2020-23
  Base Years
  2024
  Forecast Years
  2025-30
  Market Value in 2024   USD5.4 billion
  Market Value in 2030   USD13 billion
  CAGR (2025-30)   15.8%
  Leading Region   Germany
  Top Key Players Diagenode, Oncgnostics, Epigenomics AG, PerkinElmer, Roche Sequencing Solutions, EpiCypher, Cambridge Epigenetix, Promega, QIAGEN, Agilent, Bio-Rad, Pacific Biosciences, others
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, the growth of the market is further fueled by initiatives launched by the European governments. The European Commission launched the Horizon Europe Program in 2021 and it will run till 2027. This program aims to support research and innovations in Europe through funding to improve personalized medicine and healthcare diagnostics, that often use epigenetics in their operations. Additionally, countries such as the UK, France, and Germany are also integrating personalized medicines in their general patient care system, which is achieved through epigenetics diagnostics. This is done by governmental organizations such as the NHS in the UK. Therefore, continuous government support also plays a major role in driving market growth.

Furthermore, the market is further boosted by the aging population in Europe, major of whom are affected by multiple chronic diseases such as diabetes, heart & immune system-related diseases, etc. As per the European Union, about 21.6% of the region’s population is age 65 and above. This further increases the demand for epigenetics diagnostics as they help in knowing the major diseases in their early stages and treating them before they become uncontrollable. Therefore, the market has experienced significant growth in the past years due to the treatment and cost efficiency offered by it, and this trend is expected to continue in the forecast period amid the increasing older population and continuous government support.

Europe Epigenetics Diagnostic Market Driver:

Increasing Cases of Chronic Diseases Driving Market Growth – The number of cases of diseases such as cancer, heart-related diseases, nerves-related diseases, etc., are continuously increasing in this region. As per the WHO, around 20% of the deaths in Europe are caused by cancer. Also, around 32.5% of the deaths were caused by heart-related diseases in 2021. This creates a high need for detecting such problems in their earlier stages and providing the patient with personalized treatment and value-based care. This is achieved through the epigenetics diagnostic which examines the working behavior of cells and helps the healthcare provider observe the progression of treatment. This results in the increased demand for such services in Europe.

Therefore, the increasing number of chronic diseases has increased the demand for epigenetic diagnostics for early detection and personalized medication, and this trend is expected to continue in the forecast period as well

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Europe Epigenetics Diagnostic Market Trends & Development
  5. Europe Epigenetics Diagnostic Market Dynamics
    1. Drivers
    2. Challenges
  6. Europe Epigenetics Diagnostic Market Hotspot & Opportunities
  7. Europe Epigenetics Diagnostic Market Policies & Regulations
  8. Europe Epigenetics Diagnostic Market Outlook, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service
        1. Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
          1. Antibodies- Market Size & Forecast 2020-2030, USD Million
          2. Chip-Sequencing Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
          3. Bisulfite Conversion Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
          4. Whole-Genome Amplification Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
          5. 5-HMC & 5-MC Analysis Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
          6. Histones- Market Size & Forecast 2020-2030, USD Million
          7. Others- Market Size & Forecast 2020-2030, USD Million
        2. Enzymes- Market Size & Forecast 2020-2030, USD Million
          1. DNA-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million
          2. Protein-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million
          3. Others- Market Size & Forecast 2020-2030, USD Million
        3. Instruments & Accessories- Market Size & Forecast 2020-2030, USD Million
        4. Software- Market Size & Forecast 2020-2030, USD Million
        5. Services- Market Size & Forecast 2020-2030, USD Million
      2. By Method
        1. DNA Methylation- Market Size & Forecast 2020-2030, USD Million
        2. Histone Modifications- Market Size & Forecast 2020-2030, USD Million
        3. Others- Market Size & Forecast 2020-2030, USD Million
      3. By Technique
        1. NGS- Market Size & Forecast 2020-2030, USD Million
        2. PCR & qPCR- Market Size & Forecast 2020-2030, USD Million
        3. Mass Spectrometry- Market Size & Forecast 2020-2030, USD Million
        4. Sonication- Market Size & Forecast 2020-2030, USD Million
        5. Others- Market Size & Forecast 2020-2030, USD Million
      4. By Application
        1. Oncology- Market Size & Forecast 2020-2030, USD Million
        2. Metabolic Diseases- Market Size & Forecast 2020-2030, USD Million
        3. Immunology- Market Size & Forecast 2020-2030, USD Million
        4. Development Biology- Market Size & Forecast 2020-2030, USD Million
        5. Cardiovascular Diseases- Market Size & Forecast 2020-2030, USD Million
        6. Others- Market Size & Forecast 2020-2030, USD Million
      5. By End-User
        1. Academic & Research Institutes- Market Size & Forecast 2020-2030, USD Million
        2. Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2020-2030, USD Million
        3. Hospitals & Clinics- Market Size & Forecast 2020-2030, USD Million
        4. Others- Market Size & Forecast 2020-2030, USD Million
      6. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. The Netherlands
        7. Scandinavia
        8. Rest of Europe
      7. By Company
        1. Competition characteristics
        2. Revenue share
  9. The UK Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  10. Germany Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  11. France Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  12. Italy Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  13. Spain Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  14. The Netherlands Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  15. Scandinavia Epigenetics Diagnostic Market Analysis, 2020-2030
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast, 2020-2030 USD Million
      2. By Method- Market Size & Forecast, 2020-2030 USD Million
      3. By Technique- Market Size & Forecast, 2020-2030 USD Million
      4. By Application- Market Size & Forecast 2020-2030, USD Million
      5. By End-User- Market Size & Forecast 2020-2030, USD Million
  16. Europe Epigenetics Diagnostic Market Key Strategic Imperatives for Growth & Success
  17. Competition Outlook
    1. Company Profiles
      1. Diagenode
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Oncgnostics
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Epigenomics AG
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. PerkinElmer
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Roche Sequencing Solutions
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. EpiCypher
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Cambridge Epigenetix
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Promega
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. QIAGEN
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10.  Agilent
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Bio-Rad
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Pacific Biosciences
        1. Business Description
        2. Operation Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying Inquire Before Buying
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization